MORE VIDEOS
Explore more

Ductal Carcinoma In Situ (DCIS)

BREAST PATHOLOGY lecture 11, CARCINOMA BREAST, types and DUCTAL CARCINOMA IN SITU made simple
BREAST PATHOLOGY lecture 11, CARCINOMA BREAST, types and DUCTAL CARCINOMA IN SITU made simple administrator 2 Views • 2 years ago

selfless.medicose@gmail.com
Breast: Lobular carcinoma histology
Breast: Lobular carcinoma histology administrator 3 Views • 2 years ago

Description of histologic features of invasive lobular carcinoma of the breast.

Video source: Pathweb
Register for FREE access to Pathweb: https://nus.syd1.qualtrics.com..../jfe/form/SV_aeYDYT8

Pathweb online resource: https://medicine.nus.edu.sg/pathweb/
Pathweb instagram: https://www.instagram.com/pathweb/

VBHC Prize 2022 | Nominee Video Pitch | Ductal Carcinoma In Situ in the LORD-trial
VBHC Prize 2022 | Nominee Video Pitch | Ductal Carcinoma In Situ in the LORD-trial administrator 2 Views • 2 years ago

Recent Experience with DCIS Score
Recent Experience with DCIS Score administrator 4 Views • 2 years ago

The DCIS score can help patients and physicians work together to determine whether or not chemotherapy will be beneficial, based on a personal assay taken at the time of surgery. That tumor assay is then analyzed, and a recurrence score, or the likelihood of recurrence, is assigned. Here, Rick Baehner, MD and Senior Director of Pathology at Genomic Health, Inc. gives a recent example of a patient with an experience using the DCIS score.

Genomic Health is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. The company's lead product, the Oncotype DX breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS).

SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS
http://www.youtube.com/user/drjayharness

VISIT BREASTCANCERANSWERS.com FOR INFORMATIVE VIDEOS
http://www.breastcanceranswers.....com/video-categorie

SUBMIT A QUESTION
http://www.breastcanceranswers.com/ask

DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR
http://www.breastcanceranswers.....com/what-breast-can

CONNECT WITH US!
Google+: http://bit.ly/16nhEnr
Facebook: https://www.facebook.com/BreastCancerAnswers
Twitter: https://twitter.com/BreastCancerDr

______

Disclaimer: This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.

CAP education session Breast DCIS cancer Dr Barnes 2012
CAP education session Breast DCIS cancer Dr Barnes 2012 administrator 7 Views • 2 years ago

View Dr. Penny Barnes’s College of American Pathologists (CAP) Cancer Protocols Education Session on breast cancer from March 28, 2012. CAP Cancer Protocols Education Sessions are sponsored by the Canadian Partnership Against Cancer, the Canadian Association of Pathologists (CAP-ACP), and Cancer Care Ontario (CCO).

For more information, see http://www.cancerview.ca/treat....mentandsupport/synop

DCIS | Which subtype of DCIS is most likely to recur?
DCIS | Which subtype of DCIS is most likely to recur? administrator 9 Views • 2 years ago

Oncology: DCIS: The comedo subtype of ductal carcinoma in situ (DCIS) is associated with an increased risk of local recurrence after surgical resection.

Medical video lectures, medical questions and answers, medical problems and solutions, medical treatment information, medical problems in the world, medical problem list, medical student interview questions and answers ,medical student blog, medical information videos, online medical courses video series, medical symptoms and signs, medical lecture series, medical lecture videos for students, medical lecture videos, doctor vlog | Medical Tube Video | #USMLE |™Flash-Med | #Medicalstudent | #DCIS
Breast Disease -- Risk Lesions (Pt. 2) + DCIS
Breast Disease -- Risk Lesions (Pt. 2) + DCIS administrator 2 Views • 2 years ago

This video covers the second part of breast lesions characterized as "risk lesions." The features and management of lobular carcinoma in situ (LCIS) is reviewed as well as the pre-malignany ductal carcinoma in situ (DCIS). Atypical lobular hyperplasia (ALH) and atypical ductal hyperplasia (ADH) were reviewed in Part 1.
Atypical Ductal Hyperplasia
Atypical Ductal Hyperplasia administrator 1 Views • 2 years ago

Atypical Ductal Hyperplasia diagnosis, Is this breast cancer.? Dr. April Spencer explains. Could this be Ductal carcinoma in situ or DCIS? Do I have to take Tamoxifen? How can I lower my risk for future breast cancer?
Who is Eligible for the DCIS Score?
Who is Eligible for the DCIS Score? administrator 5 Views • 2 years ago

Who is eligible for the DCIS score? Here, Rick Baehner, MD and Senior Director of Pathology at Genomic Health, Inc. explains who is eligible for the DCIS score.

Genomic Health is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. The company's lead product, the Oncotype DX breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS).

SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS
http://www.youtube.com/user/drjayharness

VISIT BREASTCANCERANSWERS.com FOR INFORMATIVE VIDEOS
http://www.breastcanceranswers.....com/video-categorie

SUBMIT A QUESTION
http://www.breastcanceranswers.com/ask

DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR
http://www.breastcanceranswers.....com/what-breast-can

CONNECT WITH US!
Google+: http://bit.ly/16nhEnr
Facebook: https://www.facebook.com/BreastCancerAnswers
Twitter: https://twitter.com/BreastCancerDr

______

Disclaimer: This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.

Treating DCIS Breast Cancer: Identifying & Addressing Patient Need
Treating DCIS Breast Cancer: Identifying & Addressing Patient Need administrator 5 Views • 2 years ago

Dr. Eileen Rakovitch
MD, FRCP(C), M.Sc.

Sunnybrook Research Institute
Toronto, Ontario

DCIS, or ductal carcinoma in situ, is a non-invasive form of breast cancer. It is unlikely for DCIS to be fatal; however, in some cases DCIS can come back and at times, come back as an invasive form of breast cancer. It’s important for patients diagnosed with DCIS to have as much information as possible: educate themselves and make an informed decision on what types of treatment best suit their individual case. There is a new method of determining a patient’s specific risk of recurrence. With the latest advances in genomic testing, physicians and their patients now have the opportunity to equip themselves with more precise information to be able to guide treatment selection.

www.MyBreastCancerTreatment.org
For more information please visit: http://www.healthandfamily.ca/show/dcis

Showing 1 out of 2